Updated October 23 at 6:29pm
75 results total, viewing 1 - 10
EpiVax Inc. has received a $600,000 grant from the National Institutes of Health through the Small Business Innovation Research program to improve a vaccine for the H7N9 avian influenza virus. more
(Updated 9:57 a.m. and 1:43 p.m.) Nabsys has completed a financial restructuring and is back in business, operating out of its Clifford Street office. more
In one room at the Cambridge Innovation Center in Massachusetts, a large table is shared by a half-dozen people, plugged into laptops and oblivious to passing visitors. In a connecting hallway, overstuffed couches attract workers who would rather … more
Richard A. Andrews has been appointed chief operating officer at ProThera Biologics. more
Rhode Island ranked 33rd in the nation for venture-capital investment in the first quarter, which featured only one deal - $5 million to IlluminOss Medical Inc. more
Four years ago, MedMates was conceived at a brainstorming session about making economic growth happen in Rhode Island. David Goldsmith, co-founder of the group focused on providing a voice and opportunities for businesses in the state's … more
Kelly Nevins is the first full-time executive director of MedMates, Rhode Island’s health care technology network group. She spoke recently with PBN about its short- and long-term goals and her role with the organization. more
The I-195 Redevelopment District Commission moved closer Monday to securing the sale of five acres of land for a biological sciences and mixed-use development. more
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
EpiVax and French pharmaceutical company Ipsen recently announced a collaborative project to combat neurotoxins with novel biologic therapeutics. more
1 | 2 | 3 | 4 | 5 | 6 | 7 8 | Next »